Kate D Sutherland
A/Prof Kate Sutherland is a Laboratory Head at The Walter and Eliza Hall Institute of Medical Research (WEHI), developing state-of-the-art preclinical models of lung cancer. Kate completed her PhD in 2005 before moving to The Netherlands Cancer Institute, where she undertook Postdoctoral studies in the laboratory of Prof Anton Berns. During this time Kate generated a series of adenoviral vectors that have the ability to target cancer-associated mutations to specific lung epithelial cell types. This innovative work advanced the field by identifying the cell-of-origin of the two main types of lung cancer. In 2013, Kate returned to WEHI to start her own laboratory dedicated to understanding tumour heterogeneity in lung cancer. In this time, she has developed new approaches and technologies to study lung cancer, leading to seminal findings on genetic drivers, the immune microenvironment and the role of the metabolome in these aggressive cancers. She has been the recipient of funding from Worldwide Cancer Research, NHMRC and the Victorian Cancer Agency to support her work in designing precision medicine approaches for lung cancer patients.
Abstracts this author is presenting: